Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
688513:SHA
Chengdu Easton Biopharmaceuticals Co Ltd
CN¥63.76
-0.42%
(-0.27) 1D
Apr 29, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688513...
Open
CN¥64.08
High
CN¥64.98
Low
CN¥62.70
Mkt. cap
11.64B
Avg. vol.
3.50M
Volume
1.47M
Dividend
0.67%
Quarterly dividend
CN¥0.11
Ex dividend date
Jul 1, 2024
P/E ratio
40.39
52-wk high
CN¥80.48
52-wk low
CN¥32.55
EPS
CN¥1.58
No. of employees
1K
News stories
From sources across the web
About Chengdu Easton Biopharmaceuticals Co Ltd
CEO-
Employees1.48K
FoundedJun 1, 2009
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
348.81M
364.69M
312.26M
326.26M
Cost of goods sold
96.84M
87.18M
81.78M
73.62M
Cost of revenue
96.84M
87.18M
81.78M
73.62M
Research and development expenses
67.25M
54.95M
81.76M
72.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119.91M
136.71M
128.80M
143.86M
Operating expense
199.62M
197.59M
167.16M
212.07M
Total operating expenses
296.46M
284.77M
248.94M
285.69M
Operating income
52.34M
79.91M
63.32M
40.57M
Other non operating income
-41.85K
-228.90K
-4.37M
189.38K
EBT including unusual items
87.32M
92.35M
57.56M
47.40M
EBT excluding unusual items
56.88M
79.77M
90.38M
41.52M
Income tax expense
11.34M
8.76M
4.15M
4.12M
Effective tax rate
12.99%
9.49%
7.21%
8.69%
Other operating expenses
11.95M
4.49M
-41.45M
-4.46M
Net income
75.98M
83.59M
63.90M
50.83M
Net profit margin
21.78%
22.92%
20.46%
15.58%
Earnings per share
-
-
-
-
Interest and investment income
5.10M
733.65K
31.43M
758.95K
Interest expense
-554.90K
-615.69K
-
-
Net interest expenses
4.55M
117.96K
31.43M
758.95K
Depreciation and amortization charges
-
-
-
-
EBITDA
73.02M
100.25M
86.47M
63.72M
Gain or loss from assets sale
-
-
-29.35K
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more